Cargando…
The Combination of a Low-Dose Chemotherapeutic Agent, 5-Fluorouracil, and an Adenoviral Tumor Vaccine Has a Synergistic Benefit on Survival in a Tumor Model System
Standard cancer therapies, particularly those involving chemotherapy, are in need of modifications that both reduce short-term and long-term side effects as well as improve the overall survival of cancer patients. Here we show that combining low-dose chemotherapy with a therapeutic vaccination using...
Autores principales: | Geary, Sean M., Lemke, Caitlin D., Lubaroff, David M., Salem, Aliasger K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695864/ https://www.ncbi.nlm.nih.gov/pubmed/23840786 http://dx.doi.org/10.1371/journal.pone.0067904 |
Ejemplares similares
-
Development of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8(+) T cells in the mouse
por: Lemke, Caitlin D., et al.
Publicado: (2011) -
Prostate cancer vaccines: Update on clinical development
por: Geary, Sean M., et al.
Publicado: (2013) -
Cationic nanoparticles enhance T cell tumor infiltration and antitumor immune responses to a melanoma vaccine
por: Smith, Rasheid, et al.
Publicado: (2022) -
Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment
por: Tambunlertchai, Supreeda, et al.
Publicado: (2022) -
5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)